Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Interest Expense - Others (2018 - 2022)

Abeona Therapeutics has reported Interest Expense - Others over the past 3 years, most recently at $200000.0 for Q1 2022.

  • Quarterly results put Interest Expense - Others at $200000.0 for Q1 2022, changed N/A from a year ago — trailing twelve months through Mar 2022 was $1.5 million (changed N/A YoY), and the annual figure for FY2021 was $67000.0, down 98.37%.
  • Interest Expense - Others for Q1 2022 was $200000.0 at Abeona Therapeutics, down from $1.3 million in the prior quarter.
  • Over the last five years, Interest Expense - Others for ABEO hit a ceiling of $1.3 million in Q3 2020 and a floor of $2000.0 in Q4 2018.
  • Median Interest Expense - Others over the past 3 years was $101500.0 (2018), compared with a mean of $383000.0.